Literature DB >> 17333790

Seroprevalence of hepatitis B in Nahavand, Islamic Republic of Iran.

A H M Alizadeh1, M Ranjbar, S Ansari, A MirArab, S M Alavian, K Mohammad, P Adibi, Gh H Sadri, F Keramat, A Ardalan, M Arabi, S Gharekhani, A Ataei, Gh R Amraei, M Hosseinzadeh, S Hatami, M Zali.   

Abstract

We determined the seroprevalence of hepatitis B in Nahavand in a sample of 1824 subjects > 5 years in 2002. Face-to-face interviews were conducted and blood samples taken. The association between risk factor and hepatitis B was assessed using logistic regression. The prevalence of HBsAg positive cases was 2.3%, and HBcAb and HBsAb were isolated in 7.8% and 11.6% of the participants respectively; 11.9% were positive for both HBcAb and HBsAb. History of surgery and imprisonment were the major risk factors for infection with odds ratios of 2.14 (95% CI: 1.22-3.05) and 3.57 (95% CI: 1.68-5.4) respectively.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17333790

Source DB:  PubMed          Journal:  East Mediterr Health J        ISSN: 1020-3397            Impact factor:   1.628


  28 in total

1.  Clinical, virologic and phylogenetic features of hepatitis B infection in Iranian patients.

Authors:  Golnaz Bahramali; Majid Sadeghizadeh; Samad Amini-Bavil-Olyaee; Seyed-Moayed Alavian; Abbas Behzad-Behbahani; Ahmad Adeli; Mohammad-Reza Aghasadeghi; Safieh Amini; Fereidoun Mahboudi
Journal:  World J Gastroenterol       Date:  2008-09-21       Impact factor: 5.742

2.  Protection Provided by Hepatitis B Vaccine in Adult Population of Chaharmahal and Bakhtiari Province, Iran in 2013.

Authors:  Masoumeh Moezzi; Reza Imani
Journal:  J Clin Diagn Res       Date:  2016-04-01

3.  Persistent alanine aminotransferase elevation among the general Iranian population: prevalence and causes.

Authors:  Raika Jamali; Mahmoodreza Khonsari; Shahin Merat; Masoud Khoshnia; Elham Jafari; Alireza Bahram Kalhori; Hassan Abolghasemi; Sedighe Amini; Mahtab Maghsoudlu; Mohammad-Reza Deyhim; Houri Rezvan; Akram Pourshams
Journal:  World J Gastroenterol       Date:  2008-05-14       Impact factor: 5.742

4.  Seroepidemiology of HBV infection in South-East of iran; a population based study.

Authors:  M Salehi; S M Alavian; S V Tabatabaei; Sh Izadi; E Sanei Moghaddam; S Amini Kafi-Abad; A Gharehbaghian; S Khosravi; H Abolghasemi
Journal:  Iran Red Crescent Med J       Date:  2012-05-30       Impact factor: 0.611

5.  Distribution and risk factors of hepatitis B virus infection in the general population of Central Iran.

Authors:  Mohammad Reza Ghadir; Mojtaba Belbasi; Akram Heidari; Mahboobeh Jandagh; Iman Ahmadi; Hosseinali Habibinejad; Alireza Kabiri; Amir Hossein Ghanooni; Abolfazl Iranikhah; Seyed Moayed Alavian
Journal:  Hepat Mon       Date:  2012-02-29       Impact factor: 0.660

6.  Seroprevalence of hepatitis B virus and human immunodeficiency virus among young prisoners.

Authors:  Mehdi Ataie; Zary Nokhodian; Behrooz Ataei; Nazila Kassaian; Majid Yaran; Razieh Hassannejad
Journal:  J Res Med Sci       Date:  2013-01       Impact factor: 1.852

7.  Seroprevalence of Hepatitis B Virus Infection and Its Risk Factors in the West of Iran: A Population-based Study.

Authors:  Seyed Moayed Alavian; Seyed Vahid Tabatabaei; Teyyeb Ghadimi; Farzam Beedrapour; Sedigheh Amini Kafi-Abad; Ahmad Gharehbaghian; Hassan Abolghasemi
Journal:  Int J Prev Med       Date:  2012-11

8.  Hepatitis B seroprevalence and risk factors in adult population of chaharmahal and bakhtiari province in 2013.

Authors:  Masoumeh Moezzi; Reza Imani; Nasser Khosravi; Behrouz Pourheidar; Forouzan Ganji; Ali Karimi
Journal:  Hepat Mon       Date:  2014-05-03       Impact factor: 0.660

9.  Seroprevalence of hepatitis B markers among incarcerated intravenous drug users.

Authors:  Zary Nokhodian; Majid Yaran; Peyman Adibi; Nazila Kassaian; Marjan Meshkati; Behrooz Ataei
Journal:  J Res Med Sci       Date:  2014-03       Impact factor: 1.852

Review 10.  Hepatitis B Virus Infection in the General Population of Iran: An Updated Systematic Review and Meta-Analysis.

Authors:  Mostafa Salehi-Vaziri; Farzin Sadeghi; Amir Almasi Hashiani; Mohammad Gholami Fesharaki; Seyed Moayed Alavian
Journal:  Hepat Mon       Date:  2016-04-26       Impact factor: 0.660

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.